Canadian and California researchers say a new drug has been shown to enhance the brain’s resilience to cognitive decline caused by Alzheimer’s disease. Canadian and California researchers say a new drug has been shown to enhance the brain’s resilience to cognitive decline caused by Alzheimer’s disease.
First drug that targets ‘traffic controller’ cells in the brain could be a breakthrough in slowing progression of dementia, scientists say
